Monterey Bio Acquisition ... (MTRY)
NASDAQ: MTRY
· Real-Time Price · USD
11.14
-0.03 (-0.27%)
At close: Nov 20, 2023, 3:59 PM
Company Description
Monterey Bio Acquisition Corporation does not have significant operations.
It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry.
The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021.
Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
Monterey Bio Acquisition Corporation
| Country | United States |
| IPO Date | Nov 22, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Murat Omur |
Contact Details
Address: 17 State Street New York City, New York United States | |
| Website | https://www.montereybio.com |
Stock Details
| Ticker Symbol | MTRY |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001860663 |
| CUSIP Number | 61240F108 |
| ISIN Number | US61240F1084 |
| Employer ID | 85-2204842 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sanjeev Satyal Ph.D. | Chief Executive Officer |
| Murat Omur | Chief Executive Officer |
| Sean McGann | Chief Financial Officer |
| William McKeever | Chief Financial Officer & Director |
| Jonas Sven Magnus Grossman M.B.A. | Executive Chairman |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Dec 19, 2023 | 15-12G | Filing |
| Dec 01, 2023 | 8-K | Current Report |
| Nov 20, 2023 | 25-NSE | Filing |
| Nov 07, 2023 | 8-K | Current Report |
| Oct 13, 2023 | 8-K | Current Report |
| Aug 22, 2023 | 10-Q | Quarterly Report |
| Aug 15, 2023 | NT 10-Q | Filing |
| Jul 10, 2023 | 8-K | Current Report |
| Jun 30, 2023 | DEFA14A | Filing |